Amplification of GPR160 at 3q26.2-q26.32 was also detected in two nasopharyngeal carcinoma cell lines [15], an observation consistent with that seen in metastatic melanoma as opposed to benign samples [16]. Here, GPR160 is linked to nasopharyngeal carcinoma.